The diagnostic and triage accuracy of digital and online symptom checker tools: a systematic review
Digital and online symptom checkers are an increasingly adopted class of health
technologies that enable patients to input their symptoms and biodata to produce a set of …
technologies that enable patients to input their symptoms and biodata to produce a set of …
Patient's perception of digital symptom assessment technologies in rheumatology: results from a multicentre study
J Knitza, F Muehlensiepen, Y Ignatyev… - Frontiers in Public …, 2022 - frontiersin.org
Introduction An increasing number of digital tools, including dedicated diagnostic decision
support systems (DDSS) exist to better assess new symptoms and understand when and …
support systems (DDSS) exist to better assess new symptoms and understand when and …
[HTML][HTML] Diagnostic accuracy of a mobile AI-based symptom checker and a web-based self-referral tool in rheumatology: multicenter randomized controlled trial
Background The diagnosis of inflammatory rheumatic diseases (IRDs) is often delayed due
to unspecific symptoms and a shortage of rheumatologists. Digital diagnostic decision …
to unspecific symptoms and a shortage of rheumatologists. Digital diagnostic decision …
Digital diagnostic support in rheumatology
J Knitza, M Krusche, J Leipe - Zeitschrift für Rheumatologie, 2021 - Springer
Erst die korrekte Diagnose ermöglicht die effektive Behandlung von rheumatologischen
Erkrankungen. Die Digitalisierung hat unseren Alltag bereits wesentlich beschleunigt und …
Erkrankungen. Die Digitalisierung hat unseren Alltag bereits wesentlich beschleunigt und …
Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology …
S Kleinert, F Schuch, P Rapp, M Ronneberger… - Rheumatology …, 2024 - Springer
The categorization of axial spondyloarthritis (axSpA) into radiographic (r-axSpA) and non-
radiographic (nr-axSpA) subtypes is important in clinical trials but may be of less value in …
radiographic (nr-axSpA) subtypes is important in clinical trials but may be of less value in …
Digitally-supported patient-centered asynchronous outpatient follow-up in rheumatoid arthritis-an explorative qualitative study
R Stenzel, K Hadaschik, S May, M Grahammer… - BMC Health Services …, 2022 - Springer
Objective A steadily increasing demand and decreasing number of rheumatologists push
current rheumatology care to its limits. Long travel times and poor accessibility of …
current rheumatology care to its limits. Long travel times and poor accessibility of …
Machine learning-based improvement of an online rheumatology referral and triage system
Introduction Rheport is an online rheumatology referral system allowing automatic
appointment triaging of new rheumatology patient referrals according to the respective …
appointment triaging of new rheumatology patient referrals according to the respective …
Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis
S Kleinert, F Schuch, P Rapp, M Ronneberger… - Rheumatology …, 2023 - Springer
Spondyloarthritis may contribute to deficits in cognition. The objective of this study was to
compare cognitive abilities in patients with axial spondyloarthritis (axSpA) or psoriatic …
compare cognitive abilities in patients with axial spondyloarthritis (axSpA) or psoriatic …
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort …
PP Strunz, M Englbrecht, LM Risser, T Witte… - Rheumatology …, 2024 - Springer
In recent years Janus kinase inhibitors (JAKi) have joined tumor necrosis factor inhibitors
(TNFi) and interleukin (IL)-17 inhibitors (IL-17i) as approved disease modifying anti …
(TNFi) and interleukin (IL)-17 inhibitors (IL-17i) as approved disease modifying anti …
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German …
PP Strunz, M Englbrecht, LM Risser, T Witte… - Frontiers in …, 2024 - frontiersin.org
Objective Treatment options with disease-modifying antirheumatic drugs (DMARDs) for
psoriatic arthritis (PsA) have evolved over recent years. In addition to Janus kinase inhibitors …
psoriatic arthritis (PsA) have evolved over recent years. In addition to Janus kinase inhibitors …